NDC to RxNorm Crosswalk 43386-071 Gavilyte-h And Bisacodyl

View RxNorm Concepts, RxCUIs, Term Types

RxNorm Crosswalk Information

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The RxNorm crosswalk for NDC code 43386-071 indicates multiple RxNorm Concept Unique Identifiers known as RxCUIs associated to the product Gavilyte-h And Bisacodyl . The unique RxCUI concepts linked to this product are: 1000479, 1718983, 1718990, 1718991 and 308753. RxCUIs are identifiers that group each chemically distinct drug into a single code regardless of manufacturer or package size. Drugs mapped to the same RxCUI are considered the same drug as having the same ingredients, strengths, and dose forms. The RxNorm mapping may include repeated RxCUI concepts with different descriptions and term types.

RxCUI: 1000479

Concept: {1 (bisacodyl 5 MG Delayed Release Oral Tablet) / 1 (2000 ML) (polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution) } Pack: Term Type (TTY): GPCK - Generic Pack
{# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack

Concept: 1 (PEG-3350 210 GM / potassium chloride 0.74 GM / sodium bicarbonate 2.86 GM / sodium chloride 5.6 GM Powder for Oral Solution) / 1 (bisacodyl 5 MG Delayed Release Oral Tablet) Pack: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: PEG-3350 210 GM / potassium chloride 0.740 GM / sodium bicarbonate 2.86 GM / sodium chloride 5.6 GM Powder for 2 L Oral Solution / 1 x bisacodyl 5 MG Delayed Release Oral Tablet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1718983

Concept: polyethylene glycol-3350 210 GM / potassium chloride 0.74 GM / sodium bicarbonate 2.86 GM / sodium chloride 5.6 GM Powder for Oral Solution: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: PEG-3350 210 GM / potassium chloride 0.740 GM / sodium bicarbonate 2.86 GM / sodium chloride 5.6 GM Powder for Oral Solution: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

Concept: POLYETHYLENE GLYCOL 3350 210000 MG / K+ Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

Concept: POLYETHYLENE GLYCOL 3350 210000 MG / Pot Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1718990

Concept: Gavilyte-H Powder for Oral Solution: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution [Gavilyte-H]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Gavilyte-H Powder for Oral Solution: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

Concept: POLYETHYLENE GLYCOL 3350 210000 MG / K+ Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution [Gavilyte-H]: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

Concept: POLYETHYLENE GLYCOL 3350 210000 MG / Pot Chloride 740 MG / NaHCO3 2860 MG / NaCl 5600 MG Powder for Oral Solution [Gavilyte-H]: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1718991

Concept: {1 (bisacodyl 5 MG Delayed Release Oral Tablet) / 1 (2000 ML) (polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution [Gavilyte-H]) } Pack [Gavilyte-H and Bisacodyl]: Term Type (TTY): BPCK - Brand Name Pack
{# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name]

Concept: GaviLyte-H and Bisacodyl Bowel Prep Pack: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: Gavilyte-H and Bisacodyl Bowel Prep (PEG-3350 210 GM / sodium chloride 5.6 GM / sodium bicarbonate 2.86 GM / potassium chloride 0.74 GM) Powder for 2 L Oral Solution / 1 x bisacodyl Delayed Release Oral Tablet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 308753

Concept: bisacodyl 5 MG Delayed Release Oral Tablet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: bisacodyl 5 MG Delayed Release Oral Tablet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: bisacodyl 5 MG Enteric Coated Oral Tablet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The goal of RxNorm is to facilitate the efficient exchange of drug information among the computer systems used by hospitals, pharmacies, clinics and other organizations. To achieve this goal RxNorm provides normalized names and unique identifiers for drugs and medicines.

What is an RXCUI?

An RxCUI is machine readable unique identifier that defines the same common concept. Every name and code provided to the National Library of Medicine receives an RXCUI. Drug products that map to the same RxCUI are considered the same drug while drugs that are distinct will have different RxCUIs.

What is a Term Type (TTY)?

Term Types (TTYs) are used to specify the level of complexity of each RxCUI term.

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.